Our Authors

Prof Bogda Koczwara is a medical oncologist and a senior staff specialist at the Flinders Centre for Innovation in Cancer. Prof Koczwara completed her oncology training at the Roswell Park Cancer Institute in Buffalo, New York and received a Master in Bioethics degree from the Monash University. Her clinical interests revolve around management of breast cancer, cancer survivorship, psycho-oncology and supportive care as well as health services development, integration with primary care and cancer education for health care professionals. Prof Koczwara's interest in needs of cancer survivors have led to her developing a Survivorship Program at Flinders that aims to promote excellence in clinical care and research relating to the needs of cancer survivors. She is the National Breast Cancer Foundation Practitioner Fellow working on the chronic disease management after cancer.2 Articles


Dr Diana Adams is a Consultant Medical Oncologist at Macarthur Cancer Therapy Centre, Sydney South West Area Health Service.2 Articles


Associate Professor Mirette Saad is a Consultant Chemical Pathologist and the National Clinical Director of Molecular Genetic Pathology at Australian Clinical Labs. At Clinical Labs, A/Prof Mirette Saad leads the Molecular Genetic testing for Non-Invasive Prenatal Testing (NIPT), carrier screening, personalised drug therapy and cancer. She is a member of the RCPA Chemical Pathology Advisory Committee and a Chair of precision medicine services at Australian Clinical Labs.2 Articles


Fran Boyle is a Medical Oncologist at North Sydney’s Mater Hospital, where she is Director of the Patricia Ritchie Centre for Cancer Care and Research, and Professor of Medical Oncology. She has been involved in research and teaching in communication in health care for the past 20 years, and is currently Director of the Pam McLean Centre in the Sydney Medical School. Understanding professional burnout, and its relationship to empathy, teamwork and communication, has been a focus for the Pam McLean team. The more so as they find themselves trying to be balanced during crazy times with COVID.2 Articles


Professor Diana Sarfati (MBChB, MPH, PhD, FNZCPHM) is National Director of Cancer Control and Chief Executive of Te Aho o Te Kahu, the Cancer Control Agency in New Zealand. Her role is to provide national leadership for, and oversight of cancer control, to provide policy advice to the Government, and to be accountable for ensuring progress towards the goals and outcomes in the New Zealand Cancer Action Plan. Previously Diana was Head of the Department of Public Health and Director of the Cancer and Chronic Conditions (C3) research group at University of Otago, Wellington. She has led a large body of research relating to disparities in cancer outcomes. This work has resulted in the identification of key patient and health system factors that influence cancer survival. It has been used extensively by health policy makers, clinicians and other researchers to develop policies and practices that aim to reduce inequities in cancer outcomes.2 Articles


Emeritus Professor Ian Maddocks is an eminent palliative care specialist and a passionate advocate for world peace. A specialist physician in the Australian Administration of Papua New Guinea for 14 years, he became Foundation Dean of the Faculty of Medicine at the University of Papua New Guinea in 1971. Since 1982 he has worked with medical groups seeking to eliminate nuclear weapons. Ian was President of the Medical Association for Prevention of War when it received an Australian Peace Medal, and Vice-President of International Physicians for Prevention of Nuclear War when it received the Nobel Prize for Peace in 1985.  Since 1980 he has advocated improved care for the dying, and was first Chair of Palliative Care at Flinders University, first President of the Australian Association for Hospice and Palliative Care and first President of the Australian and New Zealand Society for Palliative Medicine. Recipient of the inaugural Bethlehem Griffiths Medal for research in palliative care, Ian is recognised internationally for his work in palliative care, tropical and preventative medicine. Now Emeritus Professor at Flinders University, he continues daily care for the terminally ill.2 Articles



Mr Lance Kawaguchi is an internationally recognised executive leader and board member, with over 25 years of global finance and banking experience, including living and working throughout North America, Europe, Asia Pacific, and the Middle East. He has a strong advocational vision for supporting people and families living with brain cancer, while advancing the foundation’s visibility and objectives with like-minded members of the global corporate and scientific community. Lance has experienced first-hand the impacts of cancer, losing his mother to the disease in 2016. In her memory, he has committed to utilising his skills and talents to positively impact and drive change in the sector. Throughout his career, Lance’s outstanding leadership and innovative approach to diversity and inclusion have seen him recognised by many peak global bodies including the Treasury Management International, prestigious BAME100 Board Talent Index and as one of UPstanding’s 100 leading ethnic minority executives.1 Articles


Dr Pearce is a health economist interested in the various costs of cancer. Her research aims to use health services research and health economics to improve cancer care by providing relevant, reliable information for decision making. Currently based at the University of Sydney School of Public Health, she teaches and conducts research in the areas of oncology patient preferences and productivity loss. Dr Pearce’s research extends work on the economics of cancer she did as a Chancellor’s Postdoctoral Research Fellow at the Centre for Health Economics Research and Evaluation (CHERE) at UTS, and as an Interdisciplinary Capacity Enhancement Award Postdoctoral Fellow at the National Cancer Registry in Ireland. Dr Pearce completed her PhD on the costs of chemotherapy side effects at CHERE in 2013, after having worked in cancer clinical trials and health services research for over 10 years.1 Articles


Penny Schofield is a Professor of Health Psychology at Swinburne, and Head of Behavioural Science at Peter MacCallum Cancer Centre, where she maintains an active research group. Penny is a behavioural scientist with over 25 years’ experience conducting research in the field of psycho-oncology. She maintains numerous leadership roles have informed research strategy, policy and service delivery to promote cancer control in Australia and overseas. Natalie Richards is a Registered Nurse with over 15 years’ experience in clinical research and digital health projects. Natalie has experience in cancer trials at the Peter MacCallum Cancer Centre and is Project Manager of a Randomised Controlled Trial NAVIGATE assessing an online treatment decision aid for men with localised, low risk prostate cancer.1 Articles